recall
saveTeva Pharmaceuticals USA, Inc recall (Cls II)
community read0 votes
Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, Single-dose 8 mL vial, Rx only, Manufactured in Greece BY: Pharmathen International S.A, Rodopi, 693 00 Greece, Manufactured For: TEVA Pharmaceuticals, Parsippany, NJ 07054, NDC 0480-9262-08. — Reason: Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer. — Status: Ongoing
view source ↗Data sources
last refreshed just now
Found something off?
same company · ±60 days · 6
- recallTeva Pharmaceuticals USA, Inc recall (Cls II)Apr 1, 2026
- recallTeva Pharmaceuticals USA, Inc recall (Cls II)Apr 1, 2026
- approvalPONLIMSI: PONLIMSI (DENOSUMAB-ADET) — FDA approvalMar 27, 2026
- recallTeva Pharmaceuticals USA, Inc recall (Cls II)Apr 15, 2026
- recallTeva Pharmaceuticals USA, Inc recall (Cls II)Apr 15, 2026
- recallTeva Pharmaceuticals USA, Inc recall (Cls II)Apr 15, 2026
comments(0)
5-min edit window · permanent after that